Mon, Sep 22, 2014, 10:34 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Immune Pharmaceuticals, Inc. Message Board

  • vkstudti vkstudti Apr 10, 2007 8:46 AM Flag


    Lets say that NP-1 gets approved, azixa gets approved, and ceplene (god willing) gets approved...long shots all except azixa, but we can hope

    annual sales (VERY CONSERVATIVELY)

    NP-1 $200M (they think $1B so i take 20%)
    ceplene $100M (they think $200M so i take 50%)
    azixa $100M (mygn says $1B and we get ~10%)

    by my crude math that is $400M in sales with expenditures of $75M last year (not gonna happen every year!!!!) we have earnings of $325M on like 50M shares already diluted and no need for further money...uhm??? earnings of like $7.50 a share with a PE of 10 gives us how much in the s/p????


3.38-0.08(-2.31%)Sep 22 3:59 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.